Skip to main content
Homepage of ProQR
  • We are ProQR
    • About ProQR Therapeutics
    • Founding story
    • Leadership
    • Contact
    • Events
  • Science
    • Science overview
    • Axiomer technology
      • How Axiomer works
    • RNA therapy
    • Presentations & Publications
    • Partnerships
  • News
    • Press Releases
    • Blogs, stories and news
    • Email alerts
  • Careers
    • Careers at ProQR
    • Vacancies
  • Investors & Media
    • Investors & Media overview
    • Press Releases
    • Events
    • Corporate presentation
    • Corporate governance
    • Financials and filings
    • Stock info
    • Analyst coverage
    • Contact us
  1. Home
Listen

Presentations & Publications

Share

  • Facebook
  • Linkedin
  • Twitter
  • Whatsapp
  • Email
Axiomer technology

Axiomer RNA editing technology

  • Internal link TIDES Europe (2022) Gerard Platenburg, Progress on Development of RNA Base Editing Technologies for Precision Medicines
  • Internal link TIDES USA (2022) Gerard Platenburg, Development of RNA Base Editing Technologies for Precision Medicines
  • Download link Axiomer Technology Overview pdf, 2.25 MB
  • Internal link JACS (2021) Erin E. Doherty et al., Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position
  • Internal link OTS (2018) Julien Boudet et al., Structure-based computational approach for optimizing oligonucleotides for A-to-I editing
  • Internal link TIDES EU (2018) Antti Aalto, Axiomer Technology - Therapeutic oligonucleotides for directing site-specific A-to-I editing by endogenous ADAR enzymes

Share page

  • Facebook
  • Linkedin
  • Twitter
  • Whatsapp
  • Email

You might like this

  • RNA science

    Our antisense oligonucleotides are designed to correct mutations in a person’s RNA. This highly precise approach aims to stop disease progression or even reverse symptoms.

    RNA illustration
  • Working at ProQR - Careers

    We are an innovative biotech company headquartered in Leiden, the Netherlands. We focus on the development of life-changing RNA therapies for severe rare and common diseases. Are you up for a challenge?

    ProQRians listening to a red chair session with our CEO
  • Press releases

    Read the latest news on our development programs, business updates and announcements. You can sign up for email alerts so you stay up to date on all things ProQR.

    Female scientist working in ProQR's laboratories

Follow us

  • Twitter (opens in new window)
  • Facebook (opens in new window)
  • Instagram (opens in new window)
  • Linkedin (opens in new window)
  • Youtube (opens in new window)
  • Soundcloud (opens in new window)
  • Contact
  • Disclaimer
  • Privacy
  • Sitemap

© 2023 ProQR Therapeutics. All Rights Reserved.

Back to top